We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Store


Applied Filter(s):
CBR Pharma Insights
clear all 4 results found
October 2017
Current and Future Trends in Rx-to-OTC Switching with Insight from Key Industry Opinion Leaders
REPORT Rx-to-OTC switching is the process in which a drug which has formerly been marketed as a prescription-only Rx drug is authorized for sale to the general public, without the need for a prescription. For patients and healt ... >
Add to basket Preview
From
$ 2,995.00
July 2017
Pharmaceutical Deal Trends 2017 Factbook: Partnerships and Acquisitions Shift Focus Towards Early Stage Development, Emerging Markets, and Biologics
REPORT Although the pharmaceutical market is continuing to witness global growth, pharmaceutical and biotechnology companies are facing challenges due to disruptive events in the healthcare market, such as increasing costs of p ... >
Add to basket Preview
From
$ 2,995.00
June 2017
Mobile Health (mHealth) Technologies: Global Market Prospects - Featuring Expert Panel Views from Industry Survey 2017
REPORT GBI Research’s latest report provides a comprehensive analysis of the mHealth landscape. GBI Research conducted an extensive industry survey of 65 experts from the pharmaceutical, medical devices, healthcare and healthc ... >
Add to basket Preview
From
$ 2,995.00
April 2017
Pharmaceutical Lifecycle Management Strategies in 2017
REPORT GBI Research’s latest report, "" provides a comprehensive assessment of product lifecycle (LCM) management strategies that are being implemented by pharmaceutical companies around the world. The pharmaceutical industry r ... >
Add to basket Preview
From
$ 2,995.00